Is There an Additional Value of Inpatient Treatment for Patients with Atopic Dermatitis?

被引：3

作者：

Van Der Schaft, Jorien ^{[1
]}

Keijzer, Welmoed W. ^{[1
]}

Sanders, Koos J. G. ^{[1
]}

De Groot, Jette. J. C. ^{[1
]}

Van Den Bersselaar, Donna L. C. M. ^{[1
]}

Van Os-Medendorp, Harmieke ^{[1
]}

Den Akker, Margreet M. Van Doorn-Op ^{[1
]}

Brudnzeel-Koomen, Carla A. F. M. ^{[1
]}

De Bruin-Weller, Marjolein S. ^{[1
]}

机构：

[1] Univ Med Ctr Utrecht, Dept Dermatol & Allergol, Room G02-124,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands

来源：

ACTA DERMATO-VENEREOLOGICA | 2016年 / 96卷 / 06期

关键词：

atopic dermatitis; admission; hospitalization; education; self-management; QUALITY-OF-LIFE; ACTIVATION-REGULATED CHEMOKINE; SEVERITY SCORE; SERUM THYMUS; SKIN-DISEASE; 6; AREA; MANAGEMENT; ECZEMA; PSORIASIS; DIAGNOSIS;

D O I：

10.2340/00015555-2410

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

An inpatient treatment and education programme has been developed for patients with difficult to control atopic dermatitis (AD), with the aim of achieving adequate self -management and long-term disease control. This observational study included adult patients diagnosed with difficult to control AD, admitted for a structured inpatient treatment and education programme. The primary outcome was the Six Area, Six Sign Atopic Dermatitis (SASSAD) score. In total, 79 patients (mean SD age 38.8 +/- 17.1 years) were included. The median duration of hospitalization was 11 days (interquartile range 8-14). The mean percentage decrease in SASSAD score between admission and discharge was 60.7%, of which 64 (81.0%) patients achieved SASSAD50. The mean percentage decrease in SASSAD score was 69.0% during followup, of which 63 (79.7%) patients still had a SASSAD50. In the majority of these patients with difficult to control AD the admission resulted in sustained disease control. This could be achieved by optimization of treatment with topical corticosteroids.

引用

页码：797 / 801

页数：5

共 21 条

[1] Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report
Akdis, C. A.
Akdis, M.
Bieber, T.
Bindslev-Jensen, C.
Boguniewicz, M.
Eigenmann, P.
Hamid, Q.
Kapp, A.
Leung, D. Y. M.
Lipozencic, J.
Luger, T. A.
Muraro, A.
Novak, N.
Platts-Mills, T. A. E.
Rosenwasser, L.
Scheynius, A.
Simons, F. E. R.
Spergel, J.
Turjanmaa, K.
Wahn, U.
Weidinger, S.
Werfel, T.
Zuberbier, T.
[J]. ALLERGY, 2006, 61 (08) : 969 - 987
[2] Hospitalization for severe skin disease improves quality of life in the United Kingdom and the United States: A comparative study
Ayyalaraju, RS
Finlay, AY
Dykes, PJ
Trent, JT
Kirsner, RS
Kerdel, FA
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (02) : 249 - 254
[3] Guidance on the diagnosis and clinical management of atopic eczema
Baron, S. E.
Cohen, S. N.
Archer, C. B.
[J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2012, 37 : 7 - 12
[4] Six area, six sign atopic dermatitis (SASSAD) severity score: A simple system for monitoring disease activity in atopic dermatitis
BerthJones, J
[J]. BRITISH JOURNAL OF DERMATOLOGY, 1996, 135 : 25 - 30
[5] Reliability testing of the Six Area, Six Sign Atopic Dermatitis severity score
Charman, CR
Venn, AJ
Williams, HC
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (06) : 1057 - 1060
[6] Efficacy of inpatient treatment for atopic dermatitis evaluated by changes in serum cortisol levels
Fukuda, Hidetsugu
Suzuki, Taku
Saotome, Atsuko
Sode, Eri
Mukai, Hideki
[J]. JOURNAL OF DERMATOLOGY, 2013, 40 (01) : 43 - 47
[7] HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44
[8] Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis
Hijnen, DJ
de Bruin-Weller, M
Oosting, B
Lebre, C
de Jong, E
Bruijnzeel-Koomen, C
Knol, E
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (02) : 334 - 340
[9] Atopic dermatitis is associated with a decrement in health-related quality of life
Kiebert, G
Sorensen, SV
Revicki, D
Fagan, SC
Doyle, JJ
Cohen, J
Fivenson, D
[J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2002, 41 (03) : 151 - 158
[10] Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity
Landheer, Janneke
de Bruin-Weller, Marjolein
Boonacker, Chantal
Hijnen, DirkJan
Bruijnzeel-Koomen, Carla
Rockmann, Heike
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (06) : 1160 - 1166

← 1 2 3 →